Einsele, H
Löffler, J
Kapp, M
Rasche, L
Mielke, S
Grigoleit, U G
Article History
First Online: 3 June 2015
Competing interests
: HE received consulting and lecture fees from Celgene, Janssen, Amgen, Onyx and Novartis. JL received grant support from Pfizer Europe. SM has received lecture fees from Deutschen Rentenversicherung, Cellex GmbH, Novartis Pharma, Shire, and grant support from Wilhelm-Sander-Stiftunq. Germany, Carreras-Leukamie-Stiftunq. The remaining authors declare no conflict of interest.